Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer

International Journal of Cancer

Volumn 137, Issue 3, 2015, Pages 504-511

  Wells, Julia E ^a,b   Howlett, Meegan ^a   Cole, Catherine H ^b   Kees, Ursula R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

cancer; CCN2; connective tissue growth factor (CTGF)

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ANTIANGIOGENIC ACTIVITY; AUTOCRINE EFFECT; B CELL ACUTE LYMPHOBLASTIC LEUKEMIA; BILE DUCT CARCINOMA; BREAST CANCER; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHONDROSARCOMA; COLORECTAL CANCER; DERMATOFIBROMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FIBROSARCOMA; GALLBLADDER CANCER; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HODGKIN DISEASE; HUMAN; ILEAL CARCINOID; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MESOTHELIOMA; METASTASIS INHIBITION; MULTIPLE MYELOMA; NEPHROBLASTOMA; NON SMALL CELL LUNG CANCER; OVARY CANCER; PANCREAS CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RHABDOMYOSARCOMA; STOMACH CANCER; STOMACH CARCINOID; STROMA CELL; THYROID CANCER; TUMOR CELL; UTERINE CERVIX CANCER; ANTIBODY SPECIFICITY; CELL MOTION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MORTALITY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); OUTCOME ASSESSMENT; PATHOLOGY; PROGNOSIS;

CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; PATIENT OUTCOME ASSESSMENT; PROGNOSIS;

EID: 84929510883     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28972     Document Type: Review

References (105)

1. Bradham DM,. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285-94.
2. Bork P,. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993; 327: 125-30.
3. Leask A,. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep 2002; 4: 136-42.
4. Shi-Wen X, Leask A, Abraham D,. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008; 19: 133-44.
5. Jun J-I, Lau LF,. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 2011; 10: 945-63.
6. Sonnylal S, Shi-Wen X, Leoni P, et al., Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 2010; 62: 1523-32.
7. Leask A, Abraham DJ,. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006; 119: 4803-10.
8. Safadi FF, Xu J, Smock SL, et al., Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 2003; 196: 51-62.
9. Arnott JA, Lambi AG, Mundy CM, et al., The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit Rev Eukaryot Gene Expr 2011; 21: 43-69.
10. De Winter P, Leoni P, Abraham D,. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 2008; 26: 80-91.
11. Kondo S, Kubota S, Shimo T, et al., Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002; 23: 769-76.
12. Babic AM, Chen C-C, Lau LF,. Fisp12/Mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alpha vbeta 3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19: 2958-66.
13. Hall-Glenn F, De Young RA, Huang B-L, et al., CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis. PLoS One 2012; 7: e30562.
14. Hall-Glenn F, Lyons K,. Roles for CCN2 in normal physiological processes. Cell Mol Life Sci 2011; 68: 3209-17.
15. Hall-Glenn F, Aivazi A, Akopyan L, et al., CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stress. J Cell Commun Signal 2013: 1-12.
16. Frazier KS, Grotendorst GR,. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 1997; 29: 153-61.
17. Hishikawa K, Oemar BS, Tanner FC, et al., Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 1999; 274: 37461-66.
18. Xiang Z-L, Zeng Z-C, Fan J, et al., Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma. Mol Biol Rep 2012: 1-6.
19. Kubo M, Kikuchi K, Nashiro K, et al., Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 1998; 139: 192-97.
20. Chang CC, Lin MT, Lin BR, et al., Effect of connective tissue growth factor on hypoxia-inducible factor 1β degradation and tumor angiogenesis. J Natl Cancer Inst 2006; 98: 984-95.
21. Li LY, Li EM, Wu ZY, et al., Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma. Dis Esophagus 2010.
22. Kasaragod AB, Lucia MS, Cabirac G, et al., Connective tissue growth factor expression in pediatric myofibroblastic tumors. Pediatr Dev Pathol 2001; 4: 37-45.
23. Chien W, Yin D, Gui D, et al., Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. Mol Cancer Res 2006; 4: 591-98.
24. Gery S, Xie D, Yin D, et al., Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 2005; 11: 7243-54.
25. Kikuchi R, Tsuda H, Kanai Y, et al., Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res 2007; 67: 7095-105.
26. Dornhofer N, Spong S, Bennewith K, et al., Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2006; 66: 5816-27.
27. Birgersdotter A, Baumforth KRN, Wei W, et al., Connective tissue growth factor is expressed in malignant cells of hodgkin lymphoma but not in other mature B-cell lymphomas. Am J Clin Pathol 2010; 133: 271-80.
28. Xie D, Yin D, Wang H-J, et al., Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004; 10: 2072-81.
29. Mazzocca A, Fransvea E, Dituri F, et al., Down-regulation of connective tissue growth factor by inhibition of transforming growth factor β blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 2010; 51: 523-34.
30. Li M-H, Sanchez T, Pappalardo A, et al., Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res 2008; 6: 1649-56.
31. Zirn B, Samans B, Spangenberg C, et al., All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 2005; 24: 5246-51.
32. McDoniels-Silvers AL, Nimri CF, Stoner GD, et al., Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002; 8: 1127-38.
33. Zeng ZJ,. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J Gastroenterol 2004; 10: 3414-8.
34. Deng Y-Z, Chen P-P, Wang Y, et al., Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through b-catenin-T-cell factor/lef signaling. J Biol Chem 2007; 282: 36571-81.
35. Lin B-R, Chang C-C, Che T-F, et al., Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology 2005; 128: 9-23.
36. Lin B-R, Chang C-C, Chen RJ-C, et al., Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer. Clin Cancer Res 2011; 17: 3077-88.
37. Kidd M, Modlin I, Shapiro M, et al., CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol 2007; 13: 5208-16.
38. Gorlov I, Sircar K, Zhao H, et al., Prioritizing genes associated with prostate cancer development. BMC Cancer 2010; 10: 599.
39. Cui L, Zhang Q, Mao Z, et al., CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumor Biol 2011; 32: 721-8.
40. Alvarez H, Corvalan A, Roa JC, et al., Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res 2008; 14: 2631-8.
41. Mao Z, Ma X, Rong Y, et al., Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-κB pathway. Cancer Sci 2011; 102: 104-10.
42. Yang M, Lin B, Chang C, et al., Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 2011; 31: 2401-11.
43. Knowles JP, Shi-Wen X, Haque Su, et al., Endothelin-1 stimulates colon cancer adjacent fibroblasts. Int J Cancer 2011; 130: 1264-72.
44. Wong Y-F, Cheung T-H, Tsao GSW, et al., Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006; 118: 2461-9.
45. Xie H, Zhao Y, Caramuta S, et al., miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One 2012; 7: e46990.
46. Fujii M, Nakanishi H, Toyoda T, et al., Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade. Cell Cycle 2012; 11: 3373-9.
47. Chang C-C, Shih J-Y, Jeng Y-M, et al., Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 2004; 96: 364-75.
48. Garcia P, Leal P, Alvarez H, et al., Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression. Arch Pathol Lab Med 2013; 137: 245-50.
49. Wang G-B, Zhou X-Y, Yuan T, et al., Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis. World J Surg 2010; 34: 2411-7.
50. Yang F,. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 2005; 65: 8887-95.
51. Shakunaga T, Ozaki T, Ohara N, et al., Expression of connective tissue growth factor in cartilaginous tumors. Cancer 2000; 89: 1466-73.
52. Rosenwald A, Wright G, Chan WC, et al., The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-47.
53. Astolfi A, De Giovanni C, Landuzzi L, et al., Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 2001; 274: 139-49.
54. Kang H, Chen I-M, Wilson CS, et al., Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood 2010; 115: 1394-405.
55. Blenk S, Engelmann J, Weniger M, et al., Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform 2007; 3: 399-420.
56. Gohongi T, Fukumura D, Boucher Y, et al., Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med 1999; 5: 1203-8.
57. Boag JM, Beesley AH, Firth MJ, et al., High expression of connective tissue growth factor in pre-B acute lymphoblastic leukaemia. Br J Haematol 2007; 138: 740-8.
58. Munemasa S, Sakai A, Kuroda Y, et al., Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not. Br J Haematol 2007; 139: 41-50.
59. Sala-Torra O, Gundacker HM, Stirewalt DL, et al., Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia. Blood 2007; 109: 3080-3.
60. Vorwerk P, Wex H, Hohmann B, et al., CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL). Br J Cancer 2000; 83: 756-60.
61. Wang M-Y, Chen P-S, Prakash E, et al., Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res 2009; 69: 3482-91.
62. Xie D, Nakachi K, Wang H, et al., Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001; 61: 8917-23.
63. Hartel M, di Mola FF, Gardini A, et al., Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg 2004; 28: 818-25.
64. GeneCards. CTGF expression in normal human tissues. LifeMap Sciences, 2013.
65. Liu L, Han Y, Wu S, et al., Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol 2008; 14: 2110-4.
66. Braig S, Wallner S, Junglas B, et al., CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Br J Cancer 2011; 105: 231-8.
67. Zhou Z-Q, Cao W-H, Xie J-J, et al., Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 2009; 9: 291.
68. Bennewith KL, Huang X, Ham CM, et al., The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 2009; 69: 775-84.
69. Garcia P, Leal P, Ili C, et al., Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro. Int J Exp Pathol 2013; 94: 195-202.
70. Zirn B, Hartmann O, Samans B, et al., Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 2006; 118: 1954-62.
71. Gardini A, Corti B, Fiorentino M, et al., Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma. Dig Liver Dis 2005; 37: 269-74.
72. Igarashi A, Hayashi N, Nashiro K, et al., Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. J Cutan Pathol 1998; 25: 143-8.
73. Edwards LA, Woolard K, Son MJ, et al., Effect of brain-and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 2011; 103: 1162-78.
74. Eguchi D, Ikenaga N, Ohuchida K, et al., Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. J Surg Res 2013;181:225-33.
75. Ijichi H, Chytil A, Gorska AE, et al., Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J Clin Invest 2011; 121: 4106-17.
76. Kwon S, Munroe X, Crawley S, et al., Expression of connective tissue growth factor in pancreatic cancer cell lines. Int J Oncol 2007; 31: 693-703.
77. Koliopanos A, Friess H, di Mola FF, et al., Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg 2002; 26: 420-7.
78. Cunningham JL, Tsolakis AV, Jacobson A, et al., Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of {alpha}-smooth muscle actin. Eur J Endocrinol 2010; 163: 691-7.
79. Mbeunkui F, Johann D, Jr,. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 2009; 63: 571-82.
80. Mueller MM, Fusenig NE,. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839-49.
81. Jia X-q, Cheng H-q, Li H, et al., Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo. Chin Med J 2011; 124: 3794-9.
82. Xiu M, Liu Y-H, Brigstock DR, et al., Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth. World J Gastroenterol 2012; 18: 7070-8.
83. Aikawa T, Gunn J, Spong SM, et al., Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther 2006; 5: 1108-16.
84. Heestand G, Pipas J, Valone F, et al., A phase I trial of the monoclonal antibody FG-3019 to connective tissue growth factor (CTGF) in locally advanced or metastatic pancreatic cancer. J Clin Oncol 2011; 29: Abstract 269.
85. Neesse A, Frese KK, Bapiro TE, et al., CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. Proc Natl Acad Sci USA 2013; 110: 12325-30.
86. Chen P-S, Wang M-Y, Wu S-N, et al., CTGF enhances the motility of breast cancer cells via an integrin-αvβ3-ERK1/2-dependent S100A4-upregulated pathway. J Cell Sci 2007; 120: 2053-65.
87. Pandey DP, Lappano R, Albanito L, et al., Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 2009; 28: 523-32.
88. Shimo T, Kubota S, Yoshioka N, et al., Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 2006; 21: 1045-59.
89. Capparelli C, Whitaker-Menezes D, Guido C, et al., CTGF drives autophagy, glycolysis, and senescence in cancer associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle 2012; 11: 2272-84.
90. Moritani NH, Kubota S, Nishida T, et al., Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line. Cancer Lett 2003; 192: 205-14.
91. Yin D, Chen W, O'Kelly J, et al., Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer 2010; 127: 2257-67.
92. Barbolina MV, Adley BP, Kelly DL, et al., Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. Int J Cancer 2009; 125: 816-25.
93. Jiang C-G, Lv L, Liu F-R, et al., Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells. Cytokine 2013;61:173-80.
94. Friedl P, Wolf K,. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-74.
95. Demuth T, Rennert JL, Hoelzinger DB, et al., Glioma cells on the run-the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 2008; 9: 54.
96. Chien W, O'Kelly J, Lu D, et al., Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 2011; 38: 1741-7.
97. Seftor EA, Meltzer PS, Kirschmann DA, et al., Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 2002; 19: 233-46.
98. Chang C-C, Hsu W-H, Wang C-C, et al., Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res 2013; 73: 4147-57.
99. Chuang J-Y, Yang W-Y, Lai C-H, et al., CTGF inhibits cell motility and COX-2 expression in oral cancer cells. Int Immunopharmacol 2011; 11: 948-54.
100. Kang Y, Siegel PM, Shu W, et al., A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3: 537-49.
101. Minn AJ, Kang Y, Serganova I, et al., Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005; 115: 44-55.
102. Casimiro S, Luis I, Fernandes A, et al., Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clin Exp Metastasis 2012: 1-10.
103. Chang C, Yang M, Lin B, et al., CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation. Cell Death Differ 2013;20:443-55.
104. Wenger C, Ellenrieder V, Alber B, et al., Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene 1999; 18: 1073-80.
105. Croci S, Landuzzi L, Astolfi A, et al., Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 2004; 64: 1730-6.